欧库可以通过诱导自而缓解大鼠中甲三酸诱导的肠炎
Tongao Yang1, Wuying Lang2, Yun Zhao1
1Hebei Key Laboratory of Specialty Animal Germplasm Resources Exploration and Innovation, Hebei Normal University of Science and Technology, Qinhuangdao, China.
Clinical and experimental pharmacology & physiology
|August 15, 2023
概括
阿库因有效地通过激活自,减少炎症和肠道损伤来治疗大鼠中甲醇酸诱导的肠炎. 这种天然化合物在控制这种有毒副作用方面表现有前途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 自然产品化学 自然产品化学
背景情况:
- 甲甲酸 (MTX) 是一种化疗药物,毒性副作用是肠炎.
- 奥库是一种天然的皮糖类糖化物,具有抗炎,抗亡和抗氧化性质.
- 调查aucubin对MTX诱导肠炎的治疗潜力对于管理治疗并发症至关重要.
研究的目的:
- 在MTX诱导肠炎的老鼠模型中探索aucubin的疗效和潜在机制.
- 为了确定在MTX肠炎的背景下,奥库是否调节炎症通路和自.
- 评估自在aucubin对MTX诱导的肠损伤的保护作用中的作用.
主要方法:
- 建立了一个MTX诱导肠炎的老鼠模型.
- 鼠被用两剂奥库 (5和10毫克/公斤) 治疗.
- 进行了病理学检查,血清生物化学分析 (D-乳酸盐,二胺氧化酶,TNF-α,IL-6),炎症酶评估 (NLRP3,分裂酶1,IL-18,IL-1β) 和自标志物 (LC3,Beclin1). 此外,还评估了自调节剂拉巴胺和抑制剂3-甲基亚丁的作用.
主要成果:
- 治疗MTX导致身体和肠道体重下降,肠道屏障受损,血清炎症标志物增加和NLRP3炎症酶激活.
- 阿库治疗显著减轻了MTX诱导的肠炎症状,减少了炎症,并抑制了NLRP3炎症酶激活.
- 阿库治疗诱导了自,这种效应对其保护作用至关重要,如拉帕米辛和3-甲基亚丁因实验所证实的那样.
结论:
- 阿库在老鼠中显示出对MTX诱导的肠炎具有显著的治疗效果.
- 奥库的保护机制包括抑制炎症和NLRP3炎症酶激活,主要通过诱导自.
- 阿库是治疗MTX诱导肠炎的潜在治疗剂,需要进一步的临床研究.
相关概念视频
01:27Autophagy
4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195